The SARS-CoV-2 pandemic is transitioning into a new phase. Besides long-term effects after infection, researchers are monitoring emerging SARS-CoV-2 variants and their impact on the antiviral immune response as well as vaccine performance.
Miltenyi Biotec stands committed to support these studies. We continuously develop new products adjusted to emerging SARS-CoV-2 variants. Furthermore, we provide tools and protocols that are ideally suited for working with infectious material.
Here, you can find relevant resources and suggestions of specific applications and technologies for your use. Our selection ranges from cell-specific products and materials to technical solutions which are time- and material-saving, yet robust in quality. Our hope is that this collection will provide you with a quick guide to your specific path of enquiry.